News
- Website Launch Corporate press release
April 2010 – Short communication concerning Metabrain’s PRO activities.
Dowload the press release
Meet us at the following events
- EFMC-ISMC 2010
Brussels, September 5-9
more info here - EASD annual meeting
Stockholm, September 20-24
Preliminary program PDF - Bio Partnering Europe
London, October 10-12
More info here - BioFit
Lille, October 26-27
more info here
Metabrain Research is a Partnering Research Organization (PRO)
- Focused on early stage drug discovery
- Specialized in metabolic disorders such as diabetes and obesity
- Driving innovation through collaborative research programs
- Exploring connections between neurodegenerative and metabolic diseases
We operate as an integrated drug discovery platform in partnership with pharmaceutical industries, biotech as well as academic institutions with applications in the food and OTC businesses.
About usKnow-how
Our expertise in energy metabolism can be applied to both metabolic disorders and neurodegenerative diseases
Know HowDiscovery Platform
Our preclinical drug discovery platform integrates medicinal chemistry and biology competencies, conceived for optimal hit-to-lead and lead optimization processes.
Discovery PlatformPartnership Offers
Our flexible approach to contract research is designed for pharma & biotech drug developers focused on metabolism, and has applications in the food and OTC businesses.
Partnering offers